GRFS

Grifols SA (Ticker: GRFS) is a leading global biopharmaceutical company headquartered in Barcelona, Spain, specializing in the development and manufacturing of innovative therapies derived from human plasma. With a comprehensive network of plasma donation centers and advanced production facilities, Grifols effectively caters to the healthcare needs of patients suffering from rare and chronic diseases. The company's strong commitment to research and development enables it to continually expand its product offerings, reinforcing its crucial role in improving patient outcomes and advancing the global healthcare industry.